Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Ochoa

Showing results (351-360 of 368) with videos related to

Pageof 37
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|June 26, 2021
Antitumor efficacy and reduced toxicity using an anti-CD137 Probody therapeuticIñaki Etxeberria, Elixabet Bolaños, Alvaro Teijeira, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 27, 2007
Innovations and challenges in renal cell carcinoma: summary statement from the Second Cambridge ConferenceMichael B Atkins, Marc S Ernstoff, Robert A Figlin, et al.
Cancer Cell|November 26, 2019
Intratumor Adoptive Transfer of IL-12 mRNA Transiently Engineered Antitumor CD8<sup>+</sup> T CellsIñaki Etxeberria, Elixabet Bolaños, Jose I Quetglas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 17, 2024
Low-Dose Ionizing γ-Radiation Elicits the Extrusion of Neutrophil Extracellular TrapsAlvaro Teijeira, Saray Garasa, Maria C Ochoa, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|September 1, 1996
A phase I randomized study of subcutaneous adjuvant IL-2 in combination with an autologous tumor vaccine in patients with advanced renal cell carcinomaR G Fenton, R G Steis, K Madara, et al.
Medrxiv : the Preprint Server for Health Sciences|April 1, 2021
Transcriptome and Functions of Granulocytic Myeloid-Derived Suppressor Cells Determine their Association with Disease Severity of COVID-19Matthew J Dean, Juan B Ochoa, Maria Sanchez-Pino, et al.
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|April 7, 2018
Efficacy and Safety of 0.6% Pazufloxacin Ophthalmic Solution Versus Moxifloxacin 0.5% and Gatifloxacin 0.5% in Subjects with Bacterial Conjunctivitis: A Randomized Clinical TrialLeopoldo Baiza-Durán, Oscar Olvera-Montaño, Arieh R Mercado-Sesma, et al.
Breast Cancer Research and Treatment|February 3, 2018
A novel patient-derived xenograft model for claudin-low triple-negative breast cancerMargarite D Matossian, Hope E Burks, Annie C Bowles, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 31, 2021
An Fc-free EGFR-specific 4-1BB-agonistic Trimerbody Displays Broad Antitumor Activity in Humanized Murine Cancer Models without ToxicityMarta Compte, Seandean L Harwood, Ainhoa Erce-Llamazares, et al.
Cell Reports. Medicine|June 27, 2025
Targeting the CD40 costimulatory receptor to improve virotherapy efficacy in diffuse midline gliomasSara Labiano, Javier Marco-Sanz, Iker Ausejo-Mauleon, et al.
Pageof 37

Showing results (351-360 of 368) with videos related to

Sort By:
Pageof 37
Proceedings of the National Academy of Sciences of the United States of America|June 26, 2021
Antitumor efficacy and reduced toxicity using an anti-CD137 Probody therapeuticIñaki Etxeberria, Elixabet Bolaños, Alvaro Teijeira, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 27, 2007
Innovations and challenges in renal cell carcinoma: summary statement from the Second Cambridge ConferenceMichael B Atkins, Marc S Ernstoff, Robert A Figlin, et al.
Cancer Cell|November 26, 2019
Intratumor Adoptive Transfer of IL-12 mRNA Transiently Engineered Antitumor CD8<sup>+</sup> T CellsIñaki Etxeberria, Elixabet Bolaños, Jose I Quetglas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 17, 2024
Low-Dose Ionizing γ-Radiation Elicits the Extrusion of Neutrophil Extracellular TrapsAlvaro Teijeira, Saray Garasa, Maria C Ochoa, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|September 1, 1996
A phase I randomized study of subcutaneous adjuvant IL-2 in combination with an autologous tumor vaccine in patients with advanced renal cell carcinomaR G Fenton, R G Steis, K Madara, et al.
Medrxiv : the Preprint Server for Health Sciences|April 1, 2021
Transcriptome and Functions of Granulocytic Myeloid-Derived Suppressor Cells Determine their Association with Disease Severity of COVID-19Matthew J Dean, Juan B Ochoa, Maria Sanchez-Pino, et al.
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|April 7, 2018
Efficacy and Safety of 0.6% Pazufloxacin Ophthalmic Solution Versus Moxifloxacin 0.5% and Gatifloxacin 0.5% in Subjects with Bacterial Conjunctivitis: A Randomized Clinical TrialLeopoldo Baiza-Durán, Oscar Olvera-Montaño, Arieh R Mercado-Sesma, et al.
Breast Cancer Research and Treatment|February 3, 2018
A novel patient-derived xenograft model for claudin-low triple-negative breast cancerMargarite D Matossian, Hope E Burks, Annie C Bowles, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 31, 2021
An Fc-free EGFR-specific 4-1BB-agonistic Trimerbody Displays Broad Antitumor Activity in Humanized Murine Cancer Models without ToxicityMarta Compte, Seandean L Harwood, Ainhoa Erce-Llamazares, et al.
Cell Reports. Medicine|June 27, 2025
Targeting the CD40 costimulatory receptor to improve virotherapy efficacy in diffuse midline gliomasSara Labiano, Javier Marco-Sanz, Iker Ausejo-Mauleon, et al.
Pageof 37